PDF
(Download)
|
- COVID-19
- Severe Acute Respiratory Syndrome (SARS)-CoV‑2
- Antiviral Activity
|
Date:
06-15-2020 | HC# 062051-642
|
Re: COVID-19 and the Potential Usefulness of Botanicals with Antiviral Activity
Hensel A, Bauer R, Heinrich M, et al.
Challenges at the time of COVID-19: Opportunities and innovations in antivirals
from nature. [published online May 20, 2020]. Planta Med. doi: 10.1055/a-1177-4396.
Severe acute respiratory syndrome
(SARS)-CoV-2 (also known as COVID-19), SARS‑CoV‑1, Middle East respiratory syndrome
(MERS)‑CoV,
influenza viruses, rhinoviruses, adenoviruses, and respiratory syncytial virus
(RSV) have plagued humans for many decades. Some antivirals are effective
(i.e., against influenza), but there are currently no known specific, highly
effective antivirals for viral pathogens in the throat and upper airways.
Coronavirus, influenza virus, and RSV
have a lipid bilayer envelope derived from the cellular membrane of the host
cell. The lipid layer of the host often contains (glyco)proteins, which
protrude and are the target of the virus. For example, influenza viruses target
and colonize epithelia in the bronchial area, and COVID-19 viral envelope
proteins bind to structures in the throat. The question arises – How can the
mouth and throat be protected against virus penetration? The envelopes of
viruses can be attacked by many exogenous compounds (e.g., solvents,
detergents, and lipophilic substances such as essential oils). The authors
question whether it is possible to achieve protection against enveloped viruses
via topical treatment of the oral mucosa.
Tannins have antimicrobial effects and
also inhibit functionality of viral envelope proteins. Proanthocyanidin is a
tannin and is present in many plants such as green tea (Camellia sinensis, Theaceae) leaf and sorrel (Rumex
acetosa, Polygonaceae) leaf. Proanthocyanidin inhibits binding of
influenza A virus, thereby preventing virus adhesion to the host cell. The
authors hypothesize that lozenges, chewing gum, or mouthwash containing tannins
could be used prophylactically to protect against infection. However, the
benefits most likely would only occur while the tannins are in the mouth (i.e.,
while sucking a lozenge). The authors point out the possibility that the brief
exposure may decrease the viral load or inhibit incoming viruses from adhering
and causing an infection. These hypotheses need to be tested.
Podophyllotoxin, a lignan from
mandrake (Podophyllum spp., Berberidaceae) root and rhizome is active against
HIV and human papillomavirus (HPV). Lignans may inhibit reverse transcriptase
activity, to inactivate HIV. Bicyclol (a novel synthetic) drug is a type of
lignan and has antiviral activity against hepatitis B virus (HBV).
Essential oils may provide antiviral
activity. Eucalyptus (Eucalyptus globulus, Eucalypteae) leaf essential
oil may reduce docking or uptake of herpes simplex virus and influenza virus,
but the main effect may be via a reduction in inflammatory reactions in the lungs.
Essential oil from bay laurel (Laurus nobilis, Lauraceae) aerial part inhibited
replication of SARS-CoV in vitro; however, it has allergenic potential. Sage (Salvia
officinalis,
Lamiaceae) leaf essential oil was also inhibitory against SARS-CoV but had a
weaker effect compared with bay laurel essential oil. Sage also contains
tannins, so the authors suggest its potential as a gargle solution in addition
to an inhalant.
The authors propose that lozenges
containing tannins or essential oils be produced as a food supplement, which
would not need the same approval as a pharmaceutical preparation. There is an
urgent need for protection strategies especially in high risk individuals, such
as elderly, immunocompromised patients, and patients with respiratory disease,
as well as for personnel in nursing homes, ambulatory care, and hospitals. The
authors point out that although it would not be ethical to conduct a
randomized, placebo-controlled study, the lozenges could be evaluated in a
non-interventional observational study.
When the immune system is weakened, a
person is more susceptible to infections. Advanced aging (> 60 years) is
associated with a reduction in B-lymphocytes and T-lymphocytes, which are
needed to fight infection. Stimulating the immune system sounds like a positive
approach. However, SARS is associated with an overreaction of the immune system
in which the immune system produces too many inflammatory signals (a cytokine
storm) and can lead to organ failure and death. Echinacea (Echinacea spp., Asteraceae) can modulate the immune system and has
antiviral effects in vitro.
During the SARS-CoV and SARS-CoV2
outbreak in Guangdong, China, traditional Chinese medicine (TCM) was used as a
treatment in > 85% of patients. The TCM treatments were commonly used
formulations of many herbs. A 2007 survey during the SARS-CoV outbreak in
China, reported that 40-60% of patients received TCM plus Western treatments.
The 10 most popularly used herbal medicines in China to treat COVID-19 were
astragalus (Astragalus membranaceus, Fabaceae), Chinese licorice (Glycyrrhizae
uralensis, Fabaceae), siler (Saposhnikovia
divaricata,
Apiaceae) root, large-headed atractylodes (bai-zhu atractylodes; Atractylodes
macrocephala, Asteraceae) rhizome, Japanese honeysuckle (Lonicera japonica, Caprifoliaceae) flower, weeping
forsythia (Forsythia suspensa, Oleaceae) fruit, cang-zhu atractylodes (Atractylodes
lancea)
rhizome, platycodon (Platycodon grandiflorum, Campanulaceae) root, Korean mint (Chinese giant hyssop; Agastache rugosa, Lamiaceae), and fortune’s holly fern
(Cyrtomium fortunei, Dryopteridaceae). The authors state that clinical trials
are needed to support the TCM treatments, and standardized treatments rather
than self-prepared formulations should be used.
As demand for herbal medicines
increases, the existing supply chains may be insufficient. The challenge is having a supply of
authentic high-quality finished products in addition to having well-designed
studies to provide evidence of efficacy.
—Heather S. Oliff, PhD
|